Share

Mutation helps ovarian survival

accreditation

A genetic mutation appears to help survival rates in women who suffer from a common type of ovarian cancer, a new study released found.

The research appearing in the January edition of the Journal of the American Medical Association (JAMA) showed the mutations were found in 6% to 15% of women with epithelial ovarian cancer (EOC).

Kelly Bolton of the National Cancer Institute, in Bethesda, Maryland and colleagues found that five-year overall survival was 36% for non-carriers of the gene mutations.

That compared to a 44% survival rate for mutations in the BRCA1 gene, and 52% in the BRCA2 gene, the research showed.

"BRCA1 carriers had a more favourable survival than non-carriers, which improved slightly after additional adjustment for stage, grade, histology, and age at diagnosis. BRCA2 carriers had a greater survival advantage compared with non-carriers, particularly after adjusting for other prognostic factors," the study found.

The study carried out a pooled analysis of 26 observational studies on ovarian cancer survival rates.

"Our study results have potentially important implications for the clinical management of patients with EOC. Most immediately, our findings can be used by health care professionals for patient counselling regarding expected survival," the authors said.

(Sapa, January 2012)

Read more:

Ovarian cancer- from natural standards

We live in a world where facts and fiction get blurred
Who we choose to trust can have a profound impact on our lives. Join thousands of devoted South Africans who look to News24 to bring them news they can trust every day. As we celebrate 25 years, become a News24 subscriber as we strive to keep you informed, inspired and empowered.
Join News24 today
heading
description
username
Show Comments ()
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE